Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness nusinersen treatment patients infantile onset later onset spinal
… studies Conjoint analyses Decision-analytic models (cost effectiveness, budget impact) Dynamic disease transmission …
Infectious Disease Models Utilize the power of infectious disease models to inform your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on realistic disease models to understand and communicate …
… a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions … citizen. Our objective is to clarify and quantify these treatment effects for the citizens of Europe.” The SIGMA …
… to monitor any vaccine that is approved for its safety and effectiveness in clinical practice. This research will be … severe adverse events as well as for monitoring the effectiveness of COVID-19 vaccines using information in …
… Selecting a time horizon Identifying current and projected treatment mix Estimating current and future drug costs …
… at the 8th European Academy of Neurology Congress. Do patients' experiences with side effects affect their …
… launched under the leadership of Jo Mauskopf. Twenty years later, we're excited to have reached this milestone in our …
… Meeting in May 2022. Ashley presented research on the cost-effectiveness of every two month versus daily pre-exposure …
… HTA recommendations on health utility measurement for your cost-utility model? Many HTA agencies make specific … not available, use utilities from the UK may be used. Cost-Effectiveness Analysis Critical Appraisal Procedure (Státní … comprising the collection of health state data from patients via a generic questionnaire and the valuation of …
… need to decide which products will be most beneficial to patients and cost-effective for health plans. The AMCP recently introduced … dossier when there are significant changes, such as new treatment guidelines, new RWE, or new phase 3 clinical trial …